|
1
|
Felcht M and Thomas M: Angiogenesis in
malignant melanoma. J Dtsch Dermatol Ges. 13:125–136. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zurac S, Neagu M, Constantin C, Cioplea M,
Nedelcu R, Bastian A, Popp C, Nichita L, Andrei R, Tebeica T, et
al: Variations in the expression of TIMP1, TIMP2 and TIMP3 in
cutaneous melanoma with regression and their possible function as
prognostic predictors. Oncol Lett. 11:3354–3360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ruszkiewicz JA, Pinkas A, Ferrer B, Peres
TV, Tsatsakis A and Aschner M: Neurotoxic effect of active
ingredients in sunscreen products, a contemporary review. Toxicol
Rep. 4:245–259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boda D, Docea AO, Calina D, Ilie MA,
Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE,
Voiculescu V, et al: Human papilloma virus: Apprehending the link
with carcinogenesis and unveiling new research avenues (Review).
Int J Oncol. 52:637–655. 2018.PubMed/NCBI
|
|
5
|
Danciu C, Oprean C, Coricovac DE, Andreea
C, Cimpean A, Radeke H, Soica C and Dehelean C: Behaviour of four
different B16 murine melanoma cell sublines: C57BL/6J skin. Int J
Exp Pathol. 96:73–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma Y, Gui Q and Lang S: Intracranial
malignant melanoma: A report of 7 cases. Oncol Lett. 10:2171–2175.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Caunii A, Oprean C, Cristea M, Ivan A,
Danciu C, Tatu C, Paunescu V, Marti D, Tzanakakis G, Spandidos DA,
et al: Effects of ursolic and oleanolic on SK-MEL-2 melanoma cells:
In vitro and in vivo assays. Int J Oncol.
51:1651–1660. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang SH, Tsatsakis AM, Tzanakakis G, Kim
HS, Le B, Sifaki M, Spandidos DA, Tsukamoto C, Golokhvast KS,
Izotov BN, et al: Soyasaponin Ag inhibits α-MSH-induced
melanogenesis in B16F10 melanoma cells via the downregulation of
TRP-2. Int J Mol Med. 40:631–636. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chalkiadaki G, Nikitovic D, Katonis P,
Berdiaki A, Tsatsakis A, Kotsikogianni I, Karamanos NK and
Tzanakakis GN: Low molecular weight heparin inhibits melanoma cell
adhesion and migration through a PKCa/JNK signaling pathway
inducing actin cytoskeleton changes. Cancer Lett. 312:235–244.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sevastre B, Sárpataki O, Stan RL, Taulescu
M, Sevastre-Berghian AC, Olah NK, Furtuna F, Hanganu D, Hangan AC,
Cenariu M, et al: Anticancer activity of Euonymus europaeus
fruits extract on human melanoma cells. Farmacia. 65:56–62.
2017.
|
|
11
|
Chamaraux-Tran TN and Piegeler T: The
amide local anesthetic lidocaine in cancer surgery - Potential
antimetastatic effects and preservation of immune cell function? A
Narrative Review. Front Med (Lausanne). 4:2352017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sumpio BE, Yun S, Cordova AC, Haga M,
Zhang J, Koh Y and Madri JA: MAPKs (ERK1/2, p38) and AKT can be
phosphorylated by shear stress independently of platelet
endothelial cell adhesion molecule-1 (CD31) in vascular endothelial
cells. J Biol Chem. 280:11185–11191. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Keohane SG, Proby CM, Newlands C, Motley
RJ, Nasr I, Mohd Mustapa MF and Slater DN; British Association of
Dermatologists (Squamous Basal Cell Carcinoma Guideline Development
Groups); Royal College of Pathologists (Skin Cancer Lead), : The
new 8th edition of TNM staging and its implications for skin
cancer: a review by the British Association of Dermatologists and
the Royal College of Pathologists, U.K. Br J Dermatol. 179:824–828.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hamano S, Sugiyama N, Yamashita S, Tanaka
M, Hayakawa M, Minamitani M, Yoshinari S and Eto Y: Intravenous
lidocaine for status epilepticus during childhood. Dev Med Child
Neurol. 48:220–222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang YC, Huang CS and Kuo CC: Lidocaine,
carbamazepine, and imipramine have partially overlapping binding
sites and additive inhibitory effect on neuronal Na+
channels. Anesthesiology. 113:160–174. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aggarwal P and Wali JP: Lidocaine in
refractory status epilepticus: A forgotten drug in the emergency
department. Am J Emerg Med. 11:243–244. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee HJ, Cho YJ, Gong HS, Rhee SH, Park HS
and Baek GH: The effect of buffered lidocaine in local anesthesia:
A prospective, randomized, double-blind study. J Hand Surg Am.
38:971–975. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou H, Peng G, Song Y, Zhang C and Wang
J: Expression of CD31 in the serum of hepatocellular carcinoma
patients and the effects of cancer cell migration and
proliferation. China J Mod Med. 31:5–9. 2015.
|
|
19
|
Chamaraux-Tran TN, Mathelin C, Aprahamian
M, Joshi GP, Tomasetto C, Diemunsch P and Akladios C: Antitumor
effects of lidocaine on human breast cancer cells: An in vitro and
in vivo experimental trial. Anticancer Res. 38:95–105.
2018.PubMed/NCBI
|
|
20
|
Neagu M, Constantin C and Tanase C:
Immune-related biomarkers for diagnosis/prognosis and therapy
monitoring of cutaneous melanoma. Expert Rev Mol Diagn. 10:897–919.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Neagu M, Constantin C and Zurac S: Immune
parameters in the prognosis and therapy monitoring of cutaneous
melanoma patients: Experience, role, and limitations. Biomed Res
Int. 2013:1079402013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Colucci R and Moretti S: The role of
stress and beta-adrenergic system in melanoma: Current knowledge
and possible therapeutic options. J Cancer Res Clin Oncol.
142:1021–1029. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Caruntu C, Boda D, Constantin C, Caruntu A
and Neagu M: Catecholamines increase in vitro proliferation of
murine B16F10 melanoma cells. Acta Endocrinol (Bucur). 10:545–558.
2014. View Article : Google Scholar
|
